I. Holst Olsen, “First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: A single institution experience”, AO, vol. 51, no. 1, pp. 97–100, Jan. 2012.